These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 32885219)

  • 1. Barriers and facilitators for colorectal cancer screening in a low-income urban community in Mexico City.
    Unger-Saldaña K; Saldaña-Tellez M; Potter MB; Van Loon K; Allen-Leigh B; Lajous M
    Implement Sci Commun; 2020; 1():64. PubMed ID: 32885219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and facilitators of implementing a multicomponent intervention to improve faecal immunochemical test (FIT) colorectal cancer screening in primary care clinics, Alberta.
    Adhikari K; Mah SS; Patterson M; Teare GF; Manalili K
    BMJ Open Qual; 2024 May; 13(2):. PubMed ID: 38802268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing an Effective Colorectal Cancer Screening Program in Egypt: A Qualitative Study of Perceptions of Egyptian Primary Care Physicians and Specialists.
    Brand Bateman L; Khamess S; Abdelmoneim SE; Arafat W; Fouad MN; Khamis Y; Omar A; Abdelmoneim RS; Scarinci I
    Oncologist; 2020 Oct; 25(10):e1525-e1531. PubMed ID: 32091658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colon Cancer Screening - Is It Time Yet?
    Bhurgri H; Samiullah S
    J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Fault-line of an earthquake": a qualitative examination of barriers and facilitators to colorectal cancer screening in rural, Eastern North Carolina.
    Jilcott Pitts SB; Lea CS; May CL; Stowe C; Hamill DJ; Walker KT; Fitzgerald TL
    J Rural Health; 2013; 29(1):78-87. PubMed ID: 23289658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers and facilitators to implementing a multilevel, multicomponent intervention promoting colorectal cancer screening in health centers: a qualitative study of key informant perspectives.
    Telles VM; Rodriguez S; Torres M; Schneider J; Haughton J; Maldonado M; Arredondo E
    BMC Health Serv Res; 2024 Mar; 24(1):404. PubMed ID: 38553723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The implementation of colorectal cancer screening interventions in low-and middle-income countries: a scoping review.
    Schliemann D; Ramanathan K; Matovu N; O'Neill C; Kee F; Su TT; Donnelly M
    BMC Cancer; 2021 Oct; 21(1):1125. PubMed ID: 34666704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer prevention in Central, Eastern European and South Caucasus countries: a review of policy approaches.
    Nonikashvili M; Kereselidze M; Toidze O; Beruchashvili T
    J Health Organ Manag; 2024 May; ahead-of-print(ahead-of-print):. PubMed ID: 38796752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative study to explore healthcare providers' perspectives on barriers and enablers to early detection of breast and cervical cancers among women attending primary healthcare clinics in Johannesburg, South Africa.
    Tshabalala G; Blanchard C; Mmoledi K; Malope D; O'Neil DS; Norris SA; Joffe M; Dietrich JJ
    PLOS Glob Public Health; 2023; 3(5):e0001826. PubMed ID: 37159437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of a novel program to support colorectal cancer screening in a community health center consortium before and after the onset of COVID-19: a qualitative study of stakeholders' perspectives.
    Santiago-Rodríguez EJ; Hoeft KS; Lugtu K; McGowen M; Ofman D; Adler J; Somsouk M; Potter MB
    Implement Sci Commun; 2023 May; 4(1):54. PubMed ID: 37218022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and facilitators of colorectal cancer screening in Asia.
    Hatamian S; Hadavandsiri F; Momenimovahed Z; Salehiniya H
    Ecancermedicalscience; 2021; 15():1285. PubMed ID: 34824608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitators and barriers to colorectal cancer screening using the immunochemical faecal occult blood test among an average-risk population in semi-rural Malaysia: A qualitative study.
    Ramanathan K; Schliemann D; Binti Ibrahim Tamin NS; Mohan D; Donnelly M; Su TT
    PLoS One; 2022; 17(12):e0279489. PubMed ID: 36580458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Survey of Provider Attitudes, Beliefs, and Perceived Barriers Regarding a Centralized Direct-Mail Colorectal Cancer Screening Approach at Community Health Centers.
    Thompson JH; Schneider JL; Rivelli JS; Petrik AF; Vollmer WM; Fuoco MJ; Coronado GD
    J Prim Care Community Health; 2019; 10():2150132719890950. PubMed ID: 31779517
    [No Abstract]   [Full Text] [Related]  

  • 14. A Qualitative Study on Formal and Informal Carers' Perceptions of Dementia Care Provision and Management in Malaysia.
    Goodson M; McLellan E; Rosli R; Tan MP; Kamaruzzaman S; Robinson L; Moloney S
    Front Public Health; 2021; 9():637484. PubMed ID: 34368037
    [No Abstract]   [Full Text] [Related]  

  • 15. Implementation challenges and successes of a population-based colorectal cancer screening program: a qualitative study of stakeholder perspectives.
    Liles EG; Schneider JL; Feldstein AC; Mosen DM; Perrin N; Rosales AG; Smith DH
    Implement Sci; 2015 Mar; 10():41. PubMed ID: 25890079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and facilitators to participate in the colorectal cancer screening programme in Flanders (Belgium): a focus group study.
    Hoeck S; Van Roy K; Willems S
    Acta Clin Belg; 2022 Feb; 77(1):37-44. PubMed ID: 32552612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary care provider perspectives on the role of community pharmacy in colorectal cancer screening: a qualitative study.
    Brenner AT; Rohweder CL; Wangen M; Atkins DL; Ceballos RM; Correa S; Ferrari RM; Issaka RB; Ittes A; Odebunmi OO; Reuland DS; Waters AR; Wheeler SB; Shah PD
    BMC Health Serv Res; 2023 Aug; 23(1):892. PubMed ID: 37612656
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.